Phreesia, Inc. $PHR Shares Bought by Probity Advisors Inc.

Probity Advisors Inc. grew its position in Phreesia, Inc. (NYSE:PHR) by 9.7% during the 2nd quarter, Holdings Channel.com reports. The firm owned 13,211 shares of the company’s stock after purchasing an additional 1,168 shares during the period. Probity Advisors Inc.’s holdings in Phreesia were worth $376,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Diversified Trust Co grew its holdings in Phreesia by 1.0% in the second quarter. Diversified Trust Co now owns 45,042 shares of the company’s stock worth $1,282,000 after purchasing an additional 426 shares during the last quarter. Arcadia Investment Management Corp MI grew its holdings in Phreesia by 0.7% in the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company’s stock worth $2,371,000 after purchasing an additional 615 shares during the last quarter. QRG Capital Management Inc. grew its holdings in Phreesia by 8.0% in the first quarter. QRG Capital Management Inc. now owns 11,118 shares of the company’s stock worth $284,000 after purchasing an additional 827 shares during the last quarter. Hsbc Holdings PLC grew its holdings in Phreesia by 9.0% in the first quarter. Hsbc Holdings PLC now owns 14,241 shares of the company’s stock worth $356,000 after purchasing an additional 1,177 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in Phreesia by 53.0% in the first quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock worth $137,000 after purchasing an additional 1,825 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Stock Performance

Shares of NYSE PHR opened at $23.11 on Wednesday. The company has a current ratio of 2.12, a quick ratio of 2.12 and a debt-to-equity ratio of 0.02. The company has a 50 day simple moving average of $25.92 and a two-hundred day simple moving average of $25.97. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $32.76. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of -55.02 and a beta of 0.68.

Phreesia (NYSE:PHR) last issued its earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.08. Phreesia had a negative net margin of 5.35% and a negative return on equity of 8.75%. The firm had revenue of $117.26 million during the quarter, compared to analysts’ expectations of $116.39 million. During the same quarter last year, the company posted ($0.03) earnings per share. The firm’s revenue was up 14.9% compared to the same quarter last year. Phreesia has set its FY 2026 guidance at EPS. As a group, analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Insider Buying and Selling at Phreesia

In related news, General Counsel Allison C. Hoffman sold 3,133 shares of the firm’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $72,936.24. Following the completion of the transaction, the general counsel owned 139,037 shares of the company’s stock, valued at $3,236,781.36. This trade represents a 2.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider David Linetsky sold 17,445 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $29.73, for a total transaction of $518,639.85. Following the transaction, the insider directly owned 174,002 shares of the company’s stock, valued at approximately $5,173,079.46. This trade represents a 9.11% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 92,244 shares of company stock worth $2,680,720. 5.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on PHR shares. Truist Financial lifted their price target on shares of Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a report on Friday, September 5th. Needham & Company LLC raised their price target on shares of Phreesia from $29.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, September 5th. Citigroup reaffirmed an “outperform” rating on shares of Phreesia in a report on Monday, September 8th. Canaccord Genuity Group raised their price target on shares of Phreesia from $34.00 to $38.00 and gave the stock a “buy” rating in a report on Friday, September 5th. Finally, Mizuho began coverage on shares of Phreesia in a report on Wednesday, August 27th. They issued an “outperform” rating and a $36.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Phreesia currently has an average rating of “Moderate Buy” and a consensus price target of $33.85.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.